These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 25923053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK.
    Clin Cancer Res; 2004 Oct 01; 10(19):6586-97. PubMed ID: 15475448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H, Teng X, Liu Z, Zhang L, Liu Z.
    J Exp Clin Cancer Res; 2015 Feb 12; 34(1):16. PubMed ID: 25887589
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ, Salama S, Al-Ahmadi A, Al-Mansouri Z, Mirza Z, Al-Ghamdi K, Al-Hamour OA, Huwait E, Gari M, Al-Qahtani MH, Al-Maghrabi J.
    Anticancer Res; 2013 Nov 12; 33(11):4779-84. PubMed ID: 24222113
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas.
    Albuquerque Pinto Rebello I, Loures de Oliveira V, Abbud LFH, Aprígio Camargos Ferreira T, Vidal APA, de Fátima Dos Santos Teixeira P.
    Endocr Relat Cancer; 2024 Feb 01; 31(2):. PubMed ID: 38029301
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative RAS mutational analysis is of great value in predicting follicular variant of papillary thyroid carcinoma.
    Hwang TS, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Park KS, Oh SY, Kim SK, Yang JH.
    Biomed Res Int; 2015 Feb 01; 2015():697068. PubMed ID: 25648502
    [Abstract] [Full Text] [Related]

  • 17. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR, Stadler ME, Deal AM, Kim HS, Shores CG, Zanation AM.
    Laryngoscope; 2011 May 01; 121(5):983-9. PubMed ID: 21520112
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L, Farag A, Zanation AM.
    Arch Otolaryngol Head Neck Surg; 2008 Jun 01; 134(6):581-6. PubMed ID: 18559722
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
    Wallander M, Layfield LJ, Jarboe E, Emerson L, Liu T, Thaker H, Holden J, Tripp S.
    Appl Immunohistochem Mol Morphol; 2010 May 01; 18(3):231-5. PubMed ID: 20042852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.